Debt-to-equity in % of IR-Med, Inc. from Q2 2022 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IR-Med, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q2 2025.
  • IR-Med, Inc. Debt-to-equity for the quarter ending June 30, 2025 was -177 %, a 238% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

IR-Med, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 -177 -305 -238% Jun 30, 2025
Q1 2025 -525 -596 -843% Mar 31, 2025
Q4 2024 -15.1K -15.1K -32637% Dec 31, 2024
Q3 2024 366 +332 +988% Sep 30, 2024
Q2 2024 129 +103 +406% Jun 30, 2024
Q1 2024 70.7 +49.4 +232% Mar 31, 2024
Q4 2023 46.4 +23.3 +101% Dec 31, 2023
Q3 2023 33.6 +5.26 +18.6% Sep 30, 2023
Q2 2023 25.4 -2.3 -8.3% Jun 30, 2023
Q1 2023 21.3 Mar 31, 2023
Q4 2022 23.1 Dec 31, 2022
Q3 2022 28.3 Sep 30, 2022
Q2 2022 27.7 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.